SAMHI Hotels Limited (NSE:SAMHI)
India · Delayed Price · Currency is INR 227.57
+1.56 (0.69%)
Aug 1, 2025, 3:30 PM IST
Sage Therapeutics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
Operating Revenue | 11,300 | 9,574 | 7,386 | 3,227 | 1,696 | Upgrade |
Other Revenue | 2.83 | 4.13 | 5.43 | 6.32 | 7.11 | Upgrade |
| 11,303 | 9,578 | 7,391 | 3,234 | 1,703 | Upgrade | |
Revenue Growth (YoY) | 18.01% | 29.59% | 128.56% | 89.90% | -71.92% | Upgrade |
Cost of Revenue | 2,992 | 3,163 | 2,078 | 1,445 | 1,211 | Upgrade |
Gross Profit | 8,311 | 6,415 | 5,313 | 1,789 | 492.33 | Upgrade |
Selling, General & Admin | 659.01 | 617.65 | 350.48 | 144.93 | 102.08 | Upgrade |
Other Operating Expenses | 3,493 | 3,031 | 2,449 | 1,493 | 1,055 | Upgrade |
Operating Expenses | 5,320 | 4,786 | 3,788 | 2,644 | 2,275 | Upgrade |
Operating Income | 2,990 | 1,629 | 1,525 | -854.97 | -1,783 | Upgrade |
Interest Expense | -2,165 | -3,281 | -5,403 | -3,367 | -3,046 | Upgrade |
Interest & Investment Income | 93.29 | 110.09 | 71.6 | 25 | 42.07 | Upgrade |
Currency Exchange Gain (Loss) | -13.89 | -15.54 | -64.65 | -16.93 | -0.13 | Upgrade |
Other Non Operating Income (Expenses) | -104.18 | -152.7 | 186.45 | -84.06 | -30.15 | Upgrade |
EBT Excluding Unusual Items | 800.99 | -1,710 | -3,685 | -4,298 | -4,817 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 68.44 | 28.8 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.31 | - | - | - | Upgrade |
Asset Writedown | 162.88 | -737.1 | 87.47 | -186.4 | -12.62 | Upgrade |
Other Unusual Items | -357.23 | 5 | 143.5 | 23.66 | 14.83 | Upgrade |
Pretax Income | 606.64 | -2,441 | -3,386 | -4,432 | -4,815 | Upgrade |
Income Tax Expense | -248.36 | -95.2 | 0.28 | 0.28 | -37.73 | Upgrade |
Earnings From Continuing Operations | 855 | -2,346 | -3,386 | -4,433 | -4,777 | Upgrade |
Net Income | 855 | -2,346 | -3,386 | -4,433 | -4,777 | Upgrade |
Net Income to Common | 855 | -2,346 | -3,386 | -4,433 | -4,777 | Upgrade |
Shares Outstanding (Basic) | 220 | 160 | 77 | 76 | 76 | Upgrade |
Shares Outstanding (Diluted) | 222 | 160 | 77 | 76 | 76 | Upgrade |
Shares Change (YoY) | 39.09% | 107.46% | 1.05% | - | 0.86% | Upgrade |
EPS (Basic) | 3.88 | -14.67 | -43.93 | -58.12 | -62.64 | Upgrade |
EPS (Diluted) | 3.84 | -14.67 | -43.93 | -58.12 | -62.64 | Upgrade |
Free Cash Flow | 2,196 | 2,368 | 2,100 | 259.22 | 209.85 | Upgrade |
Free Cash Flow Per Share | 9.87 | 14.81 | 27.25 | 3.40 | 2.75 | Upgrade |
Gross Margin | 73.53% | 66.98% | 71.88% | 55.31% | 28.91% | Upgrade |
Operating Margin | 26.46% | 17.01% | 20.63% | -26.44% | -104.70% | Upgrade |
Profit Margin | 7.56% | -24.50% | -45.81% | -137.07% | -280.54% | Upgrade |
Free Cash Flow Margin | 19.43% | 24.72% | 28.41% | 8.02% | 12.32% | Upgrade |
EBITDA | 4,079 | 2,693 | 2,422 | 90.15 | -727.51 | Upgrade |
EBITDA Margin | 36.09% | 28.12% | 32.77% | 2.79% | -42.72% | Upgrade |
D&A For EBITDA | 1,089 | 1,064 | 897.15 | 945.12 | 1,056 | Upgrade |
EBIT | 2,990 | 1,629 | 1,525 | -854.97 | -1,783 | Upgrade |
EBIT Margin | 26.46% | 17.01% | 20.63% | -26.44% | -104.70% | Upgrade |
Revenue as Reported | 11,497 | 9,787 | 7,614 | 3,331 | 1,793 | Upgrade |
Advertising Expenses | 524.25 | 487.73 | 236.83 | 99.85 | 74.15 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.